APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Morpholine and Derivatives

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Morpholine and Derivatives Market Outlook and Growth Opportunities 2026

Report ID 173313220424 December 2025192 pages

Choose your research edition.

Industry ResearchMorpholine and Derivatives Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Morpholine and Derivatives Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Morpholine and Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Morpholine and Derivatives Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Morpholine and Derivatives Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Morpholine and Derivatives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Morpholine and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Morpholine and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Morpholine and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Morpholine and Derivatives market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Morpholine and Derivatives market include Huntsman, Anhui Wotu Chemical, BASF, Jiangsu Dingsheng Chemical, Liyang Yutian Chemical, Sichuan Institute of Fine Chemical, Jiangsu Lianrun Chemical, Nippon Nyukazai and Amines & Plasticizers, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Morpholine and Derivatives market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Morpholine and Derivatives and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Morpholine and Derivatives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Morpholine and Derivatives market size, projected growth trends, production technologies, key applications, and end-use industries.

Morpholine and Derivatives Segment by Company

Huntsman

Anhui Wotu Chemical

BASF

Jiangsu Dingsheng Chemical

Liyang Yutian Chemical

Sichuan Institute of Fine Chemical

Jiangsu Lianrun Chemical

Nippon Nyukazai

Amines & Plasticizers

Morpholine and Derivatives Segment by Type

Morpholine

N-ethylmorpholine

N-methylmorpholine

Other

Morpholine and Derivatives Segment by Application

Corrosion Inhibitor

Pesticide

Rubber

Pharmaceutical

Other

Morpholine and Derivatives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Morpholine and Derivatives status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Morpholine and Derivatives market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Morpholine and Derivatives significant trends, drivers, influence factors in global and regions.

6. To analyze Morpholine and Derivatives competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Morpholine and Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Morpholine and Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Morpholine and Derivatives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Morpholine and Derivatives market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Morpholine and Derivatives industry.

Chapter 3: Detailed analysis of Morpholine and Derivatives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Morpholine and Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Morpholine and Derivatives in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Morpholine and Derivatives Industry Trends Table 2. Morpholine and Derivatives Industry Drivers Table 3. Morpholine and Derivatives Industry Opportunities and Challenges Table 4. Morpholine and Derivatives Industry Restraints Table 5. Global Morpholine and Derivatives Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Morpholine and Derivatives Revenue Share by Company (2021-2026) Table 7. Global Morpholine and Derivatives Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Morpholine and Derivatives Sales Volume Share by Company (2021-2026) Table 9. Global Morpholine and Derivatives Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Morpholine and Derivatives Company Ranking, (2024-2026) & (USD Million) Table 11. Global Morpholine and Derivatives Key Company Manufacturing Base & Headquarters Table 12. Global Morpholine and Derivatives Company, Product Type & Application Table 13. Global Morpholine and Derivatives Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Morpholine and Derivatives by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Morpholine Table 18. Significant Companies of N-ethylmorpholine Table 19. Significant Companies of N-methylmorpholine Table 20. Significant Companies of Other Table 21. Global Morpholine and Derivatives Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 22. Global Morpholine and Derivatives Sales Volume by Type (2021-2026) & (Tons) Table 23. Global Morpholine and Derivatives Sales Volume by Type (2027-2032) & (Tons) Table 24. Global Morpholine and Derivatives Sales Volume Share by Type (2021-2026) Table 25. Global Morpholine and Derivatives Sales Volume Share by Type (2027-2032) Table 26. Global Morpholine and Derivatives Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Morpholine and Derivatives Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Morpholine and Derivatives Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Morpholine and Derivatives Sales Value Share by Type (2021-2026) Table 30. Global Morpholine and Derivatives Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Corrosion Inhibitor Table 32. Significant Companies of Pesticide Table 33. Significant Companies of Rubber Table 34. Significant Companies of Pharmaceutical Table 35. Significant Companies of Other Table 36. Global Morpholine and Derivatives Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 37. Global Morpholine and Derivatives Sales Volume by Application (2021-2026) & (Tons) Table 38. Global Morpholine and Derivatives Sales Volume by Application (2027-2032) & (Tons) Table 39. Global Morpholine and Derivatives Sales Volume Share by Application (2021-2026) Table 40. Global Morpholine and Derivatives Sales Volume Share by Application (2027-2032) Table 41. Global Morpholine and Derivatives Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Morpholine and Derivatives Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Morpholine and Derivatives Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Morpholine and Derivatives Sales Value Share by Application (2021-2026) Table 45. Global Morpholine and Derivatives Sales Value Share by Application (2027-2032) Table 46. Global Morpholine and Derivatives Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 47. Global Morpholine and Derivatives Sales by Region (2021-2026) & (Tons) Table 48. Global Morpholine and Derivatives Sales Market Share by Region (2021-2026) Table 49. Global Morpholine and Derivatives Sales by Region (2027-2032) & (Tons) Table 50. Global Morpholine and Derivatives Sales Market Share by Region (2027-2032) Table 51. Global Morpholine and Derivatives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Morpholine and Derivatives Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Morpholine and Derivatives Sales Value Share by Region (2021-2026) Table 54. Global Morpholine and Derivatives Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Morpholine and Derivatives Sales Value Share by Region (2027-2032) Table 56. Global Morpholine and Derivatives Market Average Price (US$/Ton) by Region (2021-2026) Table 57. Global Morpholine and Derivatives Market Average Price (US$/Ton) by Region (2027-2032) Table 58. Global Morpholine and Derivatives Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 59. Global Morpholine and Derivatives Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Morpholine and Derivatives Sales by Country (2021-2026) & (Tons) Table 61. Global Morpholine and Derivatives Sales Market Share by Country (2021-2026) Table 62. Global Morpholine and Derivatives Sales by Country (2027-2032) & (Tons) Table 63. Global Morpholine and Derivatives Sales Market Share by Country (2027-2032) Table 64. Global Morpholine and Derivatives Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Morpholine and Derivatives Sales Value Market Share by Country (2021-2026) Table 66. Global Morpholine and Derivatives Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Morpholine and Derivatives Sales Value Market Share by Country (2027-2032) Table 68. Huntsman Company Information Table 69. Huntsman Business Overview Table 70. Huntsman Morpholine and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Huntsman Morpholine and Derivatives Product Portfolio Table 72. Huntsman Recent Development Table 73. Anhui Wotu Chemical Company Information Table 74. Anhui Wotu Chemical Business Overview Table 75. Anhui Wotu Chemical Morpholine and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Anhui Wotu Chemical Morpholine and Derivatives Product Portfolio Table 77. Anhui Wotu Chemical Recent Development Table 78. BASF Company Information Table 79. BASF Business Overview Table 80. BASF Morpholine and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. BASF Morpholine and Derivatives Product Portfolio Table 82. BASF Recent Development Table 83. Jiangsu Dingsheng Chemical Company Information Table 84. Jiangsu Dingsheng Chemical Business Overview Table 85. Jiangsu Dingsheng Chemical Morpholine and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Jiangsu Dingsheng Chemical Morpholine and Derivatives Product Portfolio Table 87. Jiangsu Dingsheng Chemical Recent Development Table 88. Liyang Yutian Chemical Company Information Table 89. Liyang Yutian Chemical Business Overview Table 90. Liyang Yutian Chemical Morpholine and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. Liyang Yutian Chemical Morpholine and Derivatives Product Portfolio Table 92. Liyang Yutian Chemical Recent Development Table 93. Sichuan Institute of Fine Chemical Company Information Table 94. Sichuan Institute of Fine Chemical Business Overview Table 95. Sichuan Institute of Fine Chemical Morpholine and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. Sichuan Institute of Fine Chemical Morpholine and Derivatives Product Portfolio Table 97. Sichuan Institute of Fine Chemical Recent Development Table 98. Jiangsu Lianrun Chemical Company Information Table 99. Jiangsu Lianrun Chemical Business Overview Table 100. Jiangsu Lianrun Chemical Morpholine and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Jiangsu Lianrun Chemical Morpholine and Derivatives Product Portfolio Table 102. Jiangsu Lianrun Chemical Recent Development Table 103. Nippon Nyukazai Company Information Table 104. Nippon Nyukazai Business Overview Table 105. Nippon Nyukazai Morpholine and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Nippon Nyukazai Morpholine and Derivatives Product Portfolio Table 107. Nippon Nyukazai Recent Development Table 108. Amines & Plasticizers Company Information Table 109. Amines & Plasticizers Business Overview Table 110. Amines & Plasticizers Morpholine and Derivatives Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Amines & Plasticizers Morpholine and Derivatives Product Portfolio Table 112. Amines & Plasticizers Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Morpholine and Derivatives Distributors List Table 116. Morpholine and Derivatives Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Morpholine and Derivatives Product Image Figure 2. Global Morpholine and Derivatives Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Morpholine and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 4. Global Morpholine and Derivatives Sales (2021-2032) & (Tons) Figure 5. Global Morpholine and Derivatives Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Morpholine and Derivatives Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Morpholine Image Figure 10. N-ethylmorpholine Image Figure 11. N-methylmorpholine Image Figure 12. Other Image Figure 13. Global Morpholine and Derivatives Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Morpholine and Derivatives Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Morpholine and Derivatives Sales Volume Share by Type (2021-2032) Figure 16. Global Morpholine and Derivatives Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Morpholine and Derivatives Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Morpholine and Derivatives Sales Value Share by Type (2021-2032) Figure 19. Corrosion Inhibitor Image Figure 20. Pesticide Image Figure 21. Rubber Image Figure 22. Pharmaceutical Image Figure 23. Other Image Figure 24. Global Morpholine and Derivatives Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 25. Global Morpholine and Derivatives Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Morpholine and Derivatives Sales Volume Share by Application (2021-2032) Figure 27. Global Morpholine and Derivatives Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Morpholine and Derivatives Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Morpholine and Derivatives Sales Value Share by Application (2021-2032) Figure 30. Global Morpholine and Derivatives Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 31. Global Morpholine and Derivatives Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Morpholine and Derivatives Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Morpholine and Derivatives Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Morpholine and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 35. North America Morpholine and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Morpholine and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Morpholine and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Morpholine and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Morpholine and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Morpholine and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 41. South America Morpholine and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Morpholine and Derivatives Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Morpholine and Derivatives Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Morpholine and Derivatives Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Morpholine and Derivatives Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Morpholine and Derivatives Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Morpholine
  • N-ethylmorpholine
  • N-methylmorpholine
  • Other
Applications
  • Corrosion Inhibitor
  • Pesticide
  • Rubber
  • Pharmaceutical
  • Other
Companies covered
  • Huntsman
  • Anhui Wotu Chemical
  • BASF
  • Jiangsu Dingsheng Chemical
  • Liyang Yutian Chemical
  • Sichuan Institute of Fine Chemical
  • Jiangsu Lianrun Chemical
  • Nippon Nyukazai
  • Amines & Plasticizers

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Morpholine and Derivatives Sales Value (2021-2032)
  4. 1.2.2 Global Morpholine and Derivatives Sales Volume (2021-2032)
  5. 1.2.3 Global Morpholine and Derivatives Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Morpholine and Derivatives Market Dynamics
  1. 2.1 Morpholine and Derivatives Industry Trends
  2. 2.2 Morpholine and Derivatives Industry Drivers
  3. 2.3 Morpholine and Derivatives Industry Opportunities and Challenges
  4. 2.4 Morpholine and Derivatives Industry Restraints
3 Morpholine and Derivatives Market by Company
  1. 3.1 Global Morpholine and Derivatives Company Revenue Ranking in 2025
  2. 3.2 Global Morpholine and Derivatives Revenue by Company (2021-2026)
  3. 3.3 Global Morpholine and Derivatives Sales Volume by Company (2021-2026)
  4. 3.4 Global Morpholine and Derivatives Average Price by Company (2021-2026)
  5. 3.5 Global Morpholine and Derivatives Company Ranking (2024-2026)
  6. 3.6 Global Morpholine and Derivatives Company Manufacturing Base and Headquarters
  7. 3.7 Global Morpholine and Derivatives Company Product Type and Application
  8. 3.8 Global Morpholine and Derivatives Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Morpholine and Derivatives Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Morpholine and Derivatives Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Morpholine and Derivatives Market by Type
  1. 4.1 Morpholine and Derivatives Type Introduction
  2. 4.1.1 Morpholine
  3. 4.1.2 N-ethylmorpholine
  4. 4.1.3 N-methylmorpholine
  5. 4.1.4 Other
  6. 4.2 Global Morpholine and Derivatives Sales Volume by Type
  7. 4.2.1 Global Morpholine and Derivatives Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Morpholine and Derivatives Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Morpholine and Derivatives Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Morpholine and Derivatives Sales Value by Type
  11. 4.3.1 Global Morpholine and Derivatives Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Morpholine and Derivatives Sales Value by Type (2021-2032)
  13. 4.3.3 Global Morpholine and Derivatives Sales Value Share by Type (2021-2032)
5 Morpholine and Derivatives Market by Application
  1. 5.1 Morpholine and Derivatives Application Introduction
  2. 5.1.1 Corrosion Inhibitor
  3. 5.1.2 Pesticide
  4. 5.1.3 Rubber
  5. 5.1.4 Pharmaceutical
  6. 5.1.5 Other
  7. 5.2 Global Morpholine and Derivatives Sales Volume by Application
  8. 5.2.1 Global Morpholine and Derivatives Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Morpholine and Derivatives Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Morpholine and Derivatives Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Morpholine and Derivatives Sales Value by Application
  12. 5.3.1 Global Morpholine and Derivatives Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Morpholine and Derivatives Sales Value by Application (2021-2032)
  14. 5.3.3 Global Morpholine and Derivatives Sales Value Share by Application (2021-2032)
6 Morpholine and Derivatives Regional Sales and Value Analysis
  1. 6.1 Global Morpholine and Derivatives Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Morpholine and Derivatives Sales by Region (2021-2032)
  3. 6.2.1 Global Morpholine and Derivatives Sales by Region: 2021-2026
  4. 6.2.2 Global Morpholine and Derivatives Sales by Region (2027-2032)
  5. 6.3 Global Morpholine and Derivatives Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Morpholine and Derivatives Sales Value by Region (2021-2032)
  7. 6.4.1 Global Morpholine and Derivatives Sales Value by Region: 2021-2026
  8. 6.4.2 Global Morpholine and Derivatives Sales Value by Region (2027-2032)
  9. 6.5 Global Morpholine and Derivatives Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Morpholine and Derivatives Sales Value (2021-2032)
  12. 6.6.2 North America Morpholine and Derivatives Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Morpholine and Derivatives Sales Value (2021-2032)
  15. 6.7.2 Europe Morpholine and Derivatives Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Morpholine and Derivatives Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Morpholine and Derivatives Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Morpholine and Derivatives Sales Value (2021-2032)
  21. 6.9.2 South America Morpholine and Derivatives Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Morpholine and Derivatives Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Morpholine and Derivatives Sales Value Share by Country, 2025 VS 2032
7 Morpholine and Derivatives Country-level Sales and Value Analysis
  1. 7.1 Global Morpholine and Derivatives Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Morpholine and Derivatives Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Morpholine and Derivatives Sales by Country (2021-2032)
  4. 7.3.1 Global Morpholine and Derivatives Sales by Country (2021-2026)
  5. 7.3.2 Global Morpholine and Derivatives Sales by Country (2027-2032)
  6. 7.4 Global Morpholine and Derivatives Sales Value by Country (2021-2032)
  7. 7.4.1 Global Morpholine and Derivatives Sales Value by Country (2021-2026)
  8. 7.4.2 Global Morpholine and Derivatives Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Morpholine and Derivatives Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Morpholine and Derivatives Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Morpholine and Derivatives Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Huntsman
  2. 8.1.1 Huntsman Company Information
  3. 8.1.2 Huntsman Business Overview
  4. 8.1.3 Huntsman Morpholine and Derivatives Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Huntsman Morpholine and Derivatives Product Portfolio
  6. 8.1.5 Huntsman Recent Developments
  7. 8.2 Anhui Wotu Chemical
  8. 8.2.1 Anhui Wotu Chemical Company Information
  9. 8.2.2 Anhui Wotu Chemical Business Overview
  10. 8.2.3 Anhui Wotu Chemical Morpholine and Derivatives Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Anhui Wotu Chemical Morpholine and Derivatives Product Portfolio
  12. 8.2.5 Anhui Wotu Chemical Recent Developments
  13. 8.3 BASF
  14. 8.3.1 BASF Company Information
  15. 8.3.2 BASF Business Overview
  16. 8.3.3 BASF Morpholine and Derivatives Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 BASF Morpholine and Derivatives Product Portfolio
  18. 8.3.5 BASF Recent Developments
  19. 8.4 Jiangsu Dingsheng Chemical
  20. 8.4.1 Jiangsu Dingsheng Chemical Company Information
  21. 8.4.2 Jiangsu Dingsheng Chemical Business Overview
  22. 8.4.3 Jiangsu Dingsheng Chemical Morpholine and Derivatives Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Dingsheng Chemical Morpholine and Derivatives Product Portfolio
  24. 8.4.5 Jiangsu Dingsheng Chemical Recent Developments
  25. 8.5 Liyang Yutian Chemical
  26. 8.5.1 Liyang Yutian Chemical Company Information
  27. 8.5.2 Liyang Yutian Chemical Business Overview
  28. 8.5.3 Liyang Yutian Chemical Morpholine and Derivatives Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Liyang Yutian Chemical Morpholine and Derivatives Product Portfolio
  30. 8.5.5 Liyang Yutian Chemical Recent Developments
  31. 8.6 Sichuan Institute of Fine Chemical
  32. 8.6.1 Sichuan Institute of Fine Chemical Company Information
  33. 8.6.2 Sichuan Institute of Fine Chemical Business Overview
  34. 8.6.3 Sichuan Institute of Fine Chemical Morpholine and Derivatives Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sichuan Institute of Fine Chemical Morpholine and Derivatives Product Portfolio
  36. 8.6.5 Sichuan Institute of Fine Chemical Recent Developments
  37. 8.7 Jiangsu Lianrun Chemical
  38. 8.7.1 Jiangsu Lianrun Chemical Company Information
  39. 8.7.2 Jiangsu Lianrun Chemical Business Overview
  40. 8.7.3 Jiangsu Lianrun Chemical Morpholine and Derivatives Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Jiangsu Lianrun Chemical Morpholine and Derivatives Product Portfolio
  42. 8.7.5 Jiangsu Lianrun Chemical Recent Developments
  43. 8.8 Nippon Nyukazai
  44. 8.8.1 Nippon Nyukazai Company Information
  45. 8.8.2 Nippon Nyukazai Business Overview
  46. 8.8.3 Nippon Nyukazai Morpholine and Derivatives Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Nippon Nyukazai Morpholine and Derivatives Product Portfolio
  48. 8.8.5 Nippon Nyukazai Recent Developments
  49. 8.9 Amines & Plasticizers
  50. 8.9.1 Amines & Plasticizers Company Information
  51. 8.9.2 Amines & Plasticizers Business Overview
  52. 8.9.3 Amines & Plasticizers Morpholine and Derivatives Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Amines & Plasticizers Morpholine and Derivatives Product Portfolio
  54. 8.9.5 Amines & Plasticizers Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Morpholine and Derivatives Value Chain Analysis
  2. 9.1.1 Morpholine and Derivatives Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Morpholine and Derivatives Sales Mode & Process
  6. 9.2 Morpholine and Derivatives Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Morpholine and Derivatives Distributors
  9. 9.2.3 Morpholine and Derivatives Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst